Načítá se...
Individualized Glycemic Control for U.S. Adults With Type 2 Diabetes: A Cost-Effectiveness Analysis
BACKGROUND: Intensive glycemic control in type 2 diabetes (glycated hemoglobin [HbA(1c)] level <7%) is an established, cost-effective standard of care. However, guidelines recommend individualizing goals on the basis of age, comorbidity, diabetes duration, and complications. OBJECTIVE: To estimat...
Uloženo v:
| Vydáno v: | Ann Intern Med |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5989575/ https://ncbi.nlm.nih.gov/pubmed/29230472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7326/M17-0537 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|